Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Spradling

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2014
Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010Philip R Spradling, Xin Tong, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|April 7, 2020
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|June 8, 2017
Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2016
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare SettingsPhilip R Spradling, Jian Xing, Loralee B Rupp, et al.
Digestive Diseases and Sciences|August 12, 2016
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort StudyMonique A Foster, Jian Xing, Anne C Moorman, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016)Mei Lu, Jia Li, Yueren Zhou, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 24, 2020
Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020Anne C Moorman, Marie A de Perio, Ronald Goldschmidt, et al.
Hepatology (Baltimore, Md.)|February 15, 2017
Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska CohortDana J T Bruden, Brian J McMahon, Lisa Townshend-Bulson, et al.
The Journal of Infectious Diseases|January 24, 2016
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster DoseMichael G Bruce, Dana Bruden, Debby Hurlburt, et al.
Digestive Diseases and Sciences|May 25, 2016
Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)Anne C Moorman, Xin Tong, Philip R Spradling, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2014
Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010Philip R Spradling, Xin Tong, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|April 7, 2020
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Journal of Clinical Gastroenterology|June 8, 2017
Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015Philip R Spradling, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2016
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare SettingsPhilip R Spradling, Jian Xing, Loralee B Rupp, et al.
Digestive Diseases and Sciences|August 12, 2016
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort StudyMonique A Foster, Jian Xing, Anne C Moorman, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016)Mei Lu, Jia Li, Yueren Zhou, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 24, 2020
Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020Anne C Moorman, Marie A de Perio, Ronald Goldschmidt, et al.
Hepatology (Baltimore, Md.)|February 15, 2017
Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska CohortDana J T Bruden, Brian J McMahon, Lisa Townshend-Bulson, et al.
The Journal of Infectious Diseases|January 24, 2016
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster DoseMichael G Bruce, Dana Bruden, Debby Hurlburt, et al.
Digestive Diseases and Sciences|May 25, 2016
Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)Anne C Moorman, Xin Tong, Philip R Spradling, et al.
Pageof 9